Edition:
India

Zosano Pharma Corp (ZSAN.OQ)

ZSAN.OQ on NASDAQ Stock Exchange Capital Market

0.64USD
24 Nov 2017
Change (% chg)

$-0.00 (-0.06%)
Prev Close
$0.64
Open
$0.62
Day's High
$0.67
Day's Low
$0.62
Volume
24,792
Avg. Vol
125,835
52-wk High
$3.53
52-wk Low
$0.56

Latest Key Developments (Source: Significant Developments)

Zosano pharma Q3 loss per share $0.20
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Zosano Pharma Corp ::Zosano pharma reports third quarter 2017 financial results and operational update.Q3 loss per share $0.20.  Full Article

Zosano Pharma Corp says sold upto $7.5 mln in equity and other financing
Monday, 29 Aug 2016 

Zosano Pharma Corp :Sold upto $7.5 million in equity and other financing -SEC Filing.  Full Article

Zosano Pharma says expect to enroll 360 subjects at approximately 35 centers across United States for trial
Thursday, 11 Aug 2016 

Zosano Pharma Corp : Q2 loss per share $0.54 . Zosano Pharma reports second quarter 2016 financial results . Says remain on track to report data in q1 2017 in m207 efficacy trial for acute migraine .Says expect to enroll three hundred and sixty subjects at approximately 35 centers across united states for trial.  Full Article

Zosano Pharma says appointed Georgia Erbez as interim CFO
Saturday, 18 Jun 2016 

Zosano Pharma Corp : Appointed Georgia Erbez as interim chief financial officer of company .Erbez will be assuming duties of Winnie Tso who is currently on a temporary medical leave of absence.  Full Article

Zosano Pharma enrolls first subject in migraine treatment trial
Friday, 17 Jun 2016 

Zosano Pharma Enrolls First Subject In Pivotal Clinical Trial For Zp : Reiterate that we expect to report pivotal efficacy data in q1 2017 .Triptan patch program for treatment of migraine.  Full Article

Zosano Pharma Corp says CFO Winnie Tso to be on temporary medical leave of absence
Saturday, 14 May 2016 

Zosano pharma corp : Zosano Pharma Corp says Winnie Tso, chief financial officer, will be on a temporary medical leave of absence, effective immediately .Zosano Pharma Corp other executives of company will assume Tso's duties until an interim chief financial officer is identified.  Full Article

Zosano Pharma reports Q1 loss per share $0.68
Friday, 13 May 2016 

Zosano Pharma Corp :Q1 loss per share $0.68.  Full Article

Zosano Pharma names John P. Walker chairman of board
Monday, 9 May 2016 

Zosano Pharma Corp : Named John P. Walker chairman of board .Bruce Steel, outgoing chairman, will continue to serve as a board member.  Full Article

Zosano Pharma Corp implements workforce reduction of 24 employees - Reuters News
Wednesday, 30 Mar 2016 

Zosano Pharma Corp:On March 24, 2016, implemented a restructuring initiative which includes a workforce reduction of 24 employees - RTRS.Workforce reduction of 24 employees represents about 38 percent of current total workforce."estimate that we will record one-time severance-related charge totaling about $0.5 million associated with workforce reduction in Q1".  Full Article

Zosano Pharma Corp announces appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer
Friday, 8 Jan 2016 

Zosano Pharma Corp:Announced the appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer, effective immediately.Alataris replaces Vikram Lamba.  Full Article

BRIEF-Zosano pharma Q3 loss per share $0.20

* Zosano pharma reports third quarter 2017 financial results and operational update